Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Invested Capital (2016 - 2025)

Medifast's Return on Invested Capital history spans 15 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 24.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.23%, down 24.0%, while the annual FY2025 figure was 0.23%, 24.0% down from the prior year.
  • Return on Invested Capital reached 0.23% in Q4 2025 per MED's latest filing, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.99% in Q3 2022 to a low of 0.23% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.49%, with a median of 0.69% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: rose 18bps in 2022, then crashed -62bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.82% in 2021, then grew by 15bps to 0.94% in 2022, then plummeted by -48bps to 0.49% in 2023, then plummeted by -98bps to 0.01% in 2024, then tumbled by -3125bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for MED's Return on Invested Capital are 0.23% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).